Frequently Asked Questions about Anavex Life Sciences Corp. (AVXL)

Name: Anavex Life Sciences Corp. (AVXL) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Anavex Life Sciences Corp. (AVXL) do?

Accepted Answer

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Pha...

Question 2

Is Anavex Life Sciences Corp. (AVXL) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of AVXL reveals an Altman Z-Score of 22.95 and a Piotroski F-Score of 2/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if AVXL fits their risk profile.

Question 3

What is the current P/E ratio for AVXL?

Accepted Answer

As of the latest trading session, Anavex Life Sciences Corp. (AVXL) has a trailing P/E ratio of -6.86.

Question 4

Who is the CEO of Anavex Life Sciences Corp.?

Accepted Answer

The current Chief Executive Officer of Anavex Life Sciences Corp. is Christopher U. Missling.

Question 5

What was AVXL's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Anavex Life Sciences Corp. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does AVXL pay a dividend?

Accepted Answer

Anavex Life Sciences Corp. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does AVXL have?

Accepted Answer

In its latest reporting period, Anavex Life Sciences Corp. generated $-0.04B in Free Cash Flow against a total debt load of $N/A.

Question 8

What is the Price-to-Book (P/B) ratio of Anavex Life Sciences Corp.?

Accepted Answer

The Price-to-Book (P/B) ratio for Anavex Life Sciences Corp. (AVXL) is currently 2.17.

Question 9

What is the Price-to-Sales (P/S) ratio of AVXL?

Accepted Answer

Based on trailing twelve-month data, Anavex Life Sciences Corp. (AVXL) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Anavex Life Sciences Corp.'s Return on Equity (ROE)?

Accepted Answer

Anavex Life Sciences Corp. (AVXL) has a Return on Equity (ROE) of -38.76%, representing its profitability relative to shareholder equity.